
Rachel Running Steitz
Examiner (ID: 15457, Phone: (571)272-1917 , Office: P/3776 )
| Most Active Art Unit | 3772 |
| Art Unit(s) | 3772, 3732, 3776 |
| Total Applications | 1619 |
| Issued Applications | 793 |
| Pending Applications | 135 |
| Abandoned Applications | 719 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4933469
[patent_doc_number] => 20080004244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Phosphono-carboxylate compounds for treating amyloidosis'
[patent_app_type] => utility
[patent_app_number] => 11/888989
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9472
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888989
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888989 | Phosphono-carboxylate compounds for treating amyloidosis | Aug 1, 2007 | Abandoned |
Array
(
[id] => 7691356
[patent_doc_number] => 20070232677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds'
[patent_app_type] => utility
[patent_app_number] => 11/724521
[patent_app_country] => US
[patent_app_date] => 2007-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17900
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11724521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/724521 | Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds | Mar 13, 2007 | Abandoned |
Array
(
[id] => 4728194
[patent_doc_number] => 20080207738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'DRUG COMBINATIONS TO TREAT DRUG RESISTANT TUMORS'
[patent_app_type] => utility
[patent_app_number] => 11/680142
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9749
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11680142
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/680142 | DRUG COMBINATIONS TO TREAT DRUG RESISTANT TUMORS | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5120758
[patent_doc_number] => 20070142473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'DOSAGE FORMS AND METHODS USING ETHACRYNIC ACID'
[patent_app_type] => utility
[patent_app_number] => 11/611454
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4921
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142473.pdf
[firstpage_image] =>[orig_patent_app_number] => 11611454
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611454 | DOSAGE FORMS AND METHODS USING ETHACRYNIC ACID | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5237287
[patent_doc_number] => 20070129444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Novel weight reduction composition and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/633698
[patent_app_country] => US
[patent_app_date] => 2006-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4566
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129444.pdf
[firstpage_image] =>[orig_patent_app_number] => 11633698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/633698 | Novel weight reduction composition and uses thereof | Dec 3, 2006 | Abandoned |
Array
(
[id] => 5194433
[patent_doc_number] => 20070082917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders'
[patent_app_type] => utility
[patent_app_number] => 11/565142
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3190
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082917.pdf
[firstpage_image] =>[orig_patent_app_number] => 11565142
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/565142 | Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5107689
[patent_doc_number] => 20070066567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Use of phospholipid arachidonic acids for increasing muscle mass in humans'
[patent_app_type] => utility
[patent_app_number] => 11/603549
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3212
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066567.pdf
[firstpage_image] =>[orig_patent_app_number] => 11603549
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/603549 | Use of phospholipid arachidonic acids for increasing muscle mass in humans | Nov 21, 2006 | Abandoned |
Array
(
[id] => 5041217
[patent_doc_number] => 20070093499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Use of dasatinib for the treatment of bone metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/583564
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5985
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11583564
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/583564 | Use of dasatinib for the treatment of bone metastasis | Oct 18, 2006 | Abandoned |
Array
(
[id] => 5041186
[patent_doc_number] => 20070093468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Methods for treating disorders associated with hyperlipidemia in a mammal'
[patent_app_type] => utility
[patent_app_number] => 11/582835
[patent_app_country] => US
[patent_app_date] => 2006-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6821
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11582835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/582835 | Methods for treating disorders associated with hyperlipidemia in a mammal | Oct 17, 2006 | Abandoned |
Array
(
[id] => 5041167
[patent_doc_number] => 20070093449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Novel IV formulation of tipifarnib'
[patent_app_type] => utility
[patent_app_number] => 11/549188
[patent_app_country] => US
[patent_app_date] => 2006-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8301
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20070093449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11549188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/549188 | Novel IV formulation of tipifarnib | Oct 12, 2006 | Abandoned |
Array
(
[id] => 4983464
[patent_doc_number] => 20070088023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Method of administration for 5-(2-chlorophenyl)-1,2-dihydro-7-fluoro-8-methoxy-3-methyl-oyrazolo[1,4]benzodiazepine'
[patent_app_type] => utility
[patent_app_number] => 11/544838
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1942
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088023.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544838 | Method of administration for 5-(2-chlorophenyl)-1,2-dihydro-7-fluoro-8-methoxy-3-methyl-oyrazolo[1,4]benzodiazepine | Oct 5, 2006 | Abandoned |
Array
(
[id] => 4944489
[patent_doc_number] => 20080081816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-03
[patent_title] => 'ANTI-INFLAMMATION ACTIVITY OF NEWLY SYNTHESIZED XANTHINE DERIVATIVES KMUP-1 AND KMUP-3'
[patent_app_type] => utility
[patent_app_number] => 11/538236
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3814
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20080081816.pdf
[firstpage_image] =>[orig_patent_app_number] => 11538236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/538236 | ANTI-INFLAMMATION ACTIVITY OF NEWLY SYNTHESIZED XANTHINE DERIVATIVES KMUP-1 AND KMUP-3 | Oct 2, 2006 | Abandoned |
Array
(
[id] => 5149455
[patent_doc_number] => 20070049515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Therapeutic agent for diabetes containing insulin resistance improving agent'
[patent_app_type] => utility
[patent_app_number] => 11/525481
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5445
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049515.pdf
[firstpage_image] =>[orig_patent_app_number] => 11525481
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/525481 | Therapeutic agent for diabetes containing insulin resistance improving agent | Sep 21, 2006 | Abandoned |
Array
(
[id] => 5142529
[patent_doc_number] => 20070004745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using PDE 5 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/387280
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5995
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004745.pdf
[firstpage_image] =>[orig_patent_app_number] => 11387280
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/387280 | Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using PDE 5 inhibitors | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5063710
[patent_doc_number] => 20070225350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Compositions and methods for treating neoplastic diseases'
[patent_app_type] => utility
[patent_app_number] => 11/293354
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13600
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225350.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293354 | Compositions and methods for treating neoplastic diseases | Dec 1, 2005 | Abandoned |
Array
(
[id] => 5649744
[patent_doc_number] => 20060135479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Phosphono-carboxylate compounds for treating amyloidosis'
[patent_app_type] => utility
[patent_app_number] => 11/246888
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9429
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11246888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/246888 | Phosphono-carboxylate compounds for treating amyloidosis | Oct 6, 2005 | Abandoned |
Array
(
[id] => 5875526
[patent_doc_number] => 20060167089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Method for inhibition or treatment of colon tumorigenesis'
[patent_app_type] => utility
[patent_app_number] => 11/210096
[patent_app_country] => US
[patent_app_date] => 2005-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3979
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167089.pdf
[firstpage_image] =>[orig_patent_app_number] => 11210096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/210096 | Method for inhibition or treatment of colon tumorigenesis | Aug 22, 2005 | Abandoned |
Array
(
[id] => 7068977
[patent_doc_number] => 20050244360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Cosmetic composition for greasy skin care, containing a carboxylic fatty acid or a derivative thereof'
[patent_app_type] => utility
[patent_app_number] => 11/176350
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4855
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176350
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176350 | Cosmetic composition for greasy skin care, containing a carboxylic fatty acid or a derivative thereof | Jul 7, 2005 | Abandoned |
Array
(
[id] => 5016879
[patent_doc_number] => 20070260088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Calcium Trifluoroacetate for Preparing Antiangiogenetic Medicaments'
[patent_app_type] => utility
[patent_app_number] => 11/630434
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 791
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20070260088.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630434 | Calcium Trifluoroacetate for Preparing Antiangiogenetic Medicaments | Jun 16, 2005 | Abandoned |
Array
(
[id] => 7244219
[patent_doc_number] => 20050271718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Sustained release propafenone hydrochloride capsules'
[patent_app_type] => utility
[patent_app_number] => 11/146006
[patent_app_country] => US
[patent_app_date] => 2005-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1156
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271718.pdf
[firstpage_image] =>[orig_patent_app_number] => 11146006
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/146006 | Sustained release propafenone hydrochloride capsules | Jun 6, 2005 | Abandoned |